Alfuzosin HCL (ER) & Dutasteride Tablets - OLFURA PLUS Tablets

Composition:

Alfuzosin 10mg + Dutasteride 0.5 mg
10*10 Alu-Alu

2,899.00

Share

Description

OLFURA PLUS Tablets – Dual Therapy for Optimal Prostate Health.

OLFURA PLUS Tablets – Alfuzosin HCL (ER) & Dutasteride Tablets formulation is a combination of alfuzosin, a selective alpha 1 blocker and dutasteride, a 5-alpha reductase inhibitor; both in combination help to manage issues related to prostate health, such as Benign Prostatic Hyperplasia (BPH), Long-Term Benefits for Prostate Health, and prostate size reduction.
Alfuzosin Alfuzosin is a selective alpha-1 adrenergic receptor antagonist that selectively inhibits alpha-1 adrenergic receptors located in the smooth muscles of the prostate, bladder neck, and urethra. This inhibition leads to muscle relaxation, which in turn improves urine flow and alleviates symptoms associated with BPH.
Dutasteride inhibits the 5-alpha-reductase enzyme, responsible for converting testosterone into dihydrotestosterone (DHT). By reducing DHT levels, it should decrease prostate volume, addressing one of the root causes of BPH.

Key Benefits of Alfuzosin HCL (ER) & Dutasteride Tablets – OLFURA PLUS Tablets
✅Comprehensive Symptoms Relief: The Combination efficiently addresses both systolic & diastolic Components of BPH by improving urinary flow and reducing prostate volume, leading to significant symptom relief.
✅Established the safety & Efficacy Profile: Demonstrated efficacy in managing BPH symptoms, and their combination has been shown to provide enhanced therapeutic benefits with a manageable side effect profile.
✅Prevention of BPH Progression: By reducing prostate size and alleviating urinary symptoms, this combination therapy helps prevent the progression of BPH, potentially reducing the need for surgical intervention.

Recommended by specialists:
👨‍⚕️Urologists –For the management of Benign Prostatic Hyperplasia (BPH) to provide relief in symptoms such as urinary hesitancy, weak stream, and incomplete bladder emptying.
👨‍⚕️General Physicians – As first-line therapy for male patients with lower urinary tract symptoms (LUTS) related to an enlarged prostate.
👨‍⚕️Geriatric Specialists – For elderly male patients with age-associated prostate enlargement, helping reduce nocturia, urinary frequency, and improving overall bladder emptying.

INDICATIONS:
Benign Prostatic Hyperplasia (BPH)
Lower Urinary Tract Symptoms (LUTS) associated with BPH
Prevention of Acute Urinary Retention (AUR)
Reduction in Prostate Size & Symptom Progression

×

Hello!

Click one of our contacts below to chat on WhatsApp

× How can I help you?